To provide antibodies that specifically bind to Kallidin or des-Arg10-Kallidin.SOLUTION: The invention provides an isolated
monoclonal antibody or
antigen binding fragment thereof configured to: a) bind specifically to Kallidin or des-Arg10-Kallidin but not specifically to
Bradykinin or des-Arg9-
Bradykinin; b) specifically bind to Kallidin or des-Arg10-Kallidin with a KD of less than 1×10-10 M; c) specifically bind to Kallidin or des-Arg10-Kallidin with a Koff of less than 1×104 s-1; and / or d) specifically bind to Kallidin or des-Arg10-Kallidin and inhibit binding to the
bradykinin B1
receptor.SELECTED DRAWING: None